|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2000036327 |
|
最近更新日期: Date of Last Refreshed on: |
2020-08-22 05:41:51 |
|
注册时间: Date of Registration: |
2020-08-22 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
扩大移动医疗(mHealth)在内蒙古地区的应用规模,以弥合数字鸿沟,减少门诊拥堵 |
|
Public title: |
Scaling up Mobile Health (mHealth) to bridge the digital divide and reduce outpatient department congestion in Inner Mongolia of China |
|
注册题目简写: |
移动医疗应用中的数字鸿沟 |
|
English Acronym: |
The digital divide in mHealth |
|
研究课题的正式科学名称: |
扩大移动医疗(mHealth)在内蒙古地区的应用规模,以弥合数字鸿沟,减少门诊拥堵 |
|
Scientific title: |
Scaling up Mobile Health (mHealth) to bridge the digital divide and reduce outpatient department congestion in Inner Mongolia of China |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
夏云露 |
研究负责人: |
曹立 |
|
Applicant: |
Yunlu Xia |
Study leader: |
Cao Li |
|
申请注册联系人电话: Applicant telephone: |
0471-6657390 |
研究负责人电话:
Study leader's |
0471-6653023 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
xyl@immu.edu.cn |
研究负责人电子邮件: Study leader's E-mail: |
caoli@immu.edu.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
内蒙古呼和浩特市金山开发区内蒙古医科大学金山校区 |
研究负责人通讯地址: |
内蒙古呼和浩特市金山开发区内蒙古医科大学金山校区 |
|
Applicant address: |
Jinshan campus, Inner Mongolia Medical University, Jinshan Development District, Hohhot, Inner Mongolia Autonomous Region, China |
Study leader's address: |
Jinshan campus, Inner Mongolia Medical University, Jinshan Development District, Hohhot, Inner Mongolia Autonomous Region, China |
|
申请注册联系人邮政编码: Applicant postcode: |
010110 |
研究负责人邮政编码: Study leader's postcode: |
010110 |
|
申请人所在单位: |
内蒙古医科大学 |
||
|
Applicant's institution: |
Inner Mongolia Medical University |
||
|
研究负责人所在单位: |
内蒙古医科大学 |
||
|
Affiliation of the Leader: |
Inner Mongolia Medical University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
REC.63-306-18-1 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
宋卡王子大学医学院伦理委员会 |
||
|
Name of the ethic committee: |
Human Research Ethics Committee, Faculty of medicine |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2020-08-20 00:00:00 | ||
|
伦理委员会联系人: |
Asso.prof Bunsuk Nittharak |
||
|
Contact Name of the ethic committee: |
Asso.prof Bunsuk Nittharak |
||
|
伦理委员会联系地址: |
泰国宋卡王子大学医学院办公楼4层伦理委员会办公室 |
||
|
Contact Address of the ethic committee: |
Office of HREC, 4th floor, Administrative Building, Faculty of Medicine, Prince of Songkla University, Thailand |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+66-7-4451157 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
medpsu.ec@gmail.com. |
|
研究实施负责(组长)单位: |
内蒙古医科大学 |
||||||||||||||||||||||||||||||||||||||||||||
|
Primary sponsor: |
Inner Mongolia Medical University |
||||||||||||||||||||||||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
内蒙古呼和浩特市通道北路5号 |
||||||||||||||||||||||||||||||||||||||||||||
|
Primary sponsor's address: |
No.5, Tongdao North Road, Hohhot, Inner Mongolia |
||||||||||||||||||||||||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
经费或物资来源: |
宋卡王子大学 |
||||||||||||||||||||||||||||||||||||||||||||
|
Source(s) of funding: |
Prince of Songkla University |
||||||||||||||||||||||||||||||||||||||||||||
|
研究疾病: |
不适用 |
||||||||||||||||||||||||||||||||||||||||||||
|
Target disease: |
Not applicable |
||||||||||||||||||||||||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||||||||||||||||||||||||
|
研究设计: |
整群随机分组 |
||||||||||||||||||||||||||||||||||||||||||||
|
Study design: |
Cluster randomization |
||||||||||||||||||||||||||||||||||||||||||||
|
研究目的: |
(1) 定义移动医疗资源成功使用 a)描述内蒙古地区医院移动医疗系统状况 b) 从利益攸关者的角度定义移动医疗资源的成功使用 (2)记录移动医疗成功使用率和社会经济决定因素 a) 记录门诊大楼客户密度随时间变化情况 b) 调查移动医疗资源成功使用率 c) 确定社会经济因素和移动医疗资源成功使用的关系 (3)评价扩大移动医疗规模对弥合数字鸿沟的作用 a)评价扩大移动医疗规模对移动医疗资源成功使用的效果 b)评价扩大移动医疗规模对门诊大楼客户密度的影响 c)扩大移动医疗规模对门诊客户满意度的影响 |
||||||||||||||||||||||||||||||||||||||||||||
|
Objectives of Study: |
Objective 1: Define successful mHealth use a) To describe the system of mHealth in hospitals of Inner Mongolia b) To define the successful mHealth use from the stakeholders of mHealth Objective 2: Document the prevalence and socioeconomic determinants of successful mHealth use a) To document the client density of outpatient departments over time b) To examine the prevalence of successful mHealth use among clients in study hospitals in inner Mongolia. c) To identify socioeconomic status factors associated with successful mHealth use. Objective 3: Evaluate the effect of scaling up mHealth to bridge the digital divide a) To assess the effect of scaling up mHealth on the use of mHealth provided by the hospitals. b) To assess the effect of scaling up mHealth on client density in the OPD. c) To assess the effect of scaling up mHealth on client satisfaction in the OPD. |
||||||||||||||||||||||||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
纳入标准: |
(1) 管理人员、职员和信息化工程师 |
||||||||||||||||||||||||||||||||||||||||||||
|
Inclusion criteria |
(1) Admin.staff, clerk, IT persons |
||||||||||||||||||||||||||||||||||||||||||||
|
排除标准: |
(1) 认知障碍 |
||||||||||||||||||||||||||||||||||||||||||||
|
Exclusion criteria: |
(1) Cognitive impairment |
||||||||||||||||||||||||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2020-10-01 00:00:00至 To 2021-01-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2020-09-01 00:00:00 至 To 2020-10-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
利用电脑产生的随机序列。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Random numbers will be produced by a computer. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
盲法不适用此研究. |
|
Blinding: |
Blinding can not be applied due to the nature of this study. |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
试验完成后6个月内,通过中国临床试验注册中心的ResMan平台进行原始数据的共享(http://www.medresman.org/login.aspx) 及 智慧医大, https://yun.immu.edu.cn。 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Within 6 months after the trial complete, we will share IPD based on the ResMan platform (http://www.medresman.org/login.aspx),and immu, https://yun.immu.edu.cn,202106 |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
调查问卷,Epidata, R |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Questionnaires,Epidata, R |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
无/No |